New Leaders Council
Education • Non-profit • Social Impact
New Leaders Council is a 501(c)(3) organization dedicated to transforming leadership in the United States by providing innovative training and support to a new generation of leaders. Focusing on equity and inclusion, NLC empowers local changemakers, particularly those from historically marginalized communities, by offering a place-based learning experience through the NLC Institute. The organization fosters collaboration and builds a national network of alumni who are equipped to drive cultural and electoral progress, addressing the nation’s most pressing challenges with bold and visionary leadership.
CEO, Gene Therapy
Job not on LinkedIn
November 5
New Leaders Council
Education • Non-profit • Social Impact
New Leaders Council is a 501(c)(3) organization dedicated to transforming leadership in the United States by providing innovative training and support to a new generation of leaders. Focusing on equity and inclusion, NLC empowers local changemakers, particularly those from historically marginalized communities, by offering a place-based learning experience through the NLC Institute. The organization fosters collaboration and builds a national network of alumni who are equipped to drive cultural and electoral progress, addressing the nation’s most pressing challenges with bold and visionary leadership.
📋 Description
• Lead the company’s overall strategy, growth, and fundraising, securing seed and Series A investment • Drive the scientific and clinical roadmap in collaboration with the CSO toward IND readiness for the CMT2D program while expanding the broader tRNA platform • Build and inspire a multidisciplinary team that combines scientific excellence with entrepreneurial focus • Establish strong partnerships with investors, academic collaborators, pharmaceutical partners, and patient foundations • Represent XtRNA Bio externally, communicating our vision, progress, and potential to the biotech and investment communities
🎯 Requirements
• Advanced degree (PhD or MD) in Life Sciences, Biotechnology, Genetics, or a related field; business training (MBA or equivalent) is an advantage • Proven experience in leading or scaling biotech or pharmaceutical ventures (ideally within RNA therapeutics, gene therapy, or rare disease) • Demonstrated success in fundraising, including venture capital and strategic partnerships • Proven track record in strategic transactions, including co-development partnerships, M&A, or successful exits with biotech or pharmaceutical companies. • Track record of translating early-stage scientific innovation into clinical development and tangible company value • Strong scientific understanding of delivery technologies such as AAV capsids or related gene therapies and RNA biology and genetic disease mechanisms • Familiarity with regulatory pathways, translational medicine, and early clinical development for rare diseases • Entrepreneurial, hands-on, and comfortable operating in a dynamic, high-growth environment
🏖️ Benefits
• Primarily equity-based compensation • Modest base salary until fundraising
Apply Now